{
    "2018-10-23": [
        [
            {
                "time": "2023-12-23",
                "original_text": "有29家公司获重要股东增减持，汉钟精机已被连续增持103次",
                "features": {
                    "keywords": [
                        "汉钟精机",
                        "重要股东",
                        "增持"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "工业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-12-24",
                "original_text": "长春高新：业绩符合预期，制药业务高速增长持续",
                "features": {
                    "keywords": [
                        "长春高新",
                        "业绩",
                        "制药业务",
                        "高速增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-12-24",
                "original_text": "长春高新董事会秘书张德申增持0.38万股",
                "features": {
                    "keywords": [
                        "长春高新",
                        "董事会秘书",
                        "增持"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-12-25",
                "original_text": "医药行业：板块估值进入可投资区间静待市场反转",
                "features": {
                    "keywords": [
                        "医药行业",
                        "板块估值",
                        "投资区间",
                        "市场反转"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-12-26",
                "original_text": "78股获券商买入评级：闰土股份目标涨幅达97.7%",
                "features": {
                    "keywords": [
                        "券商买入评级",
                        "闰土股份",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "化工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-12-27",
                "original_text": "长春高新:生物医药业务推动持续高速增长",
                "features": {
                    "keywords": [
                        "长春高新",
                        "生物医药业务",
                        "高速增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}